Back
Atea Pharmaceuticals Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44
AVIR
Atea Pharmaceuticals
Last Price:
$3.37
Seasonality Move:
4.83%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and AVIR is experiencing selling pressure, which indicates risk of future bearish movement.
Atea Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.61 | Sell |
| 20-day SMA: | 3.56 | Sell |
| 50-day SMA: | 3.21 | Buy |
| 200-day SMA: | 3.18 | Buy |
| 8-day EMA: | 3.54 | Sell |
| 20-day EMA: | 3.51 | Sell |
| 50-day EMA: | 3.32 | Buy |
| 200-day EMA: | 3.24 | Buy |
Atea Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 44.92 | Sell |
| Chaikin Money Flow: | -345776 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.28 - 3.68) | Sell |
| Bollinger Bands (100): | (2.8 - 3.38) | Buy |
Atea Pharmaceuticals Technical Analysis
| Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Atea Pharmaceuticals Stock
Is Atea Pharmaceuticals Stock a Buy?
-
Atea Pharmaceuticals share price is 3.36 while AVIR 8-day simple moving average is 3.61, which is a Sell signal.
-
The stock price of AVIR is 3.36 while Atea Pharmaceuticals 20-day SMA is 3.56, which makes it a Sell.
-
Atea Pharmaceuticals 50-day simple moving average is 3.21 while AVIR share price is 3.36, making it a Buy technically.
-
AVIR stock price is 3.36 and Atea Pharmaceuticals 200-day simple moving average is 3.18, creating a Buy signal.
AVIR Technical Analysis vs Fundamental Analysis
Sell
44
Atea Pharmaceuticals (AVIR)
is a Sell
Is Atea Pharmaceuticals a Buy or a Sell?
-
Atea Pharmaceuticals stock is rated a SellThe current Atea Pharmaceuticals [AVIR] share price is $3.36. The Score for AVIR is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
Atea Pharmaceuticals Stock Info
Market Cap:
287.5M
Price in USD:
3.36
Share Volume:
345.8K
Atea Pharmaceuticals 52-Week Range
52-Week High:
4.15
52-Week Low:
2.46
Sell
44
Atea Pharmaceuticals (AVIR)
is a Sell
Atea Pharmaceuticals Share Price Forecast
-
What is the Atea Pharmaceuticals stock price today?The Atea Pharmaceuticals stock price is 3.36 USD today.
-
Will AVIR stock go up or go down?Atea Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Atea Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Atea Pharmaceuticals is overvalued.
Is Atea Pharmaceuticals Stock a Buy?
-
Atea Pharmaceuticals share price is 3.36 while AVIR 8-day exponential moving average is 3.54, which is a Sell signal.
-
The stock price of AVIR is 3.36 while Atea Pharmaceuticals 20-day EMA is 3.51, which makes it a Sell.
-
Atea Pharmaceuticals 50-day exponential moving average is 3.32 while AVIR share price is 3.36, making it a Buy technically.
-
AVIR stock price is 3.36 and Atea Pharmaceuticals 200-day simple moving average is 3.24, creating a Buy signal.
Fundamental Analysis of Atea Pharmaceuticals
Is Atea Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.05 per share, a decrease this year of $0.21 per share, and an increase next year of $0.38 per share.
Technical Analysis of Atea Pharmaceuticals
Should I short Atea Pharmaceuticals stock?
-
AVIR Moving Average Covergence Divergence (MACD) indicator is 0.08, suggesting Atea Pharmaceuticals is a Buy
-
Atea Pharmaceuticals Relative Strength Index (RSI) is 44.92, which suggest Atea Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Atea Pharmaceuticals is (3.28 - 3.68), which suggest Atea Pharmaceuticals is a Buy
-
The Bollinger Bands (100) for Atea Pharmaceuticals is (2.8 - 3.38), which suggest Atea Pharmaceuticals is a Buy
* Atea Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.